This bill requires private group and individual health plans to cover certain insulin products for people 26 years old or younger. For those covered insulin products, plans may not apply any deductible and may not charge more than the lesser of $35 or 25 percent of the negotiated price per 30-day supply (after price concessions). "Selected insulin products" means at least one product of each dosage form and each type of insulin when available, as chosen by the plan. Cost-sharing payments under the cap count toward any plan deductible or out-of-pocket maximum. The bill adds matching requirements across the Public Health Service Act, the Affordable Care Act rules for certain plans, ERISA-covered group plans, and the Internal Revenue Code. The rules take effect for plan years beginning on or after January 1, 2026. The Secretaries of HHS, Labor, and the Treasury may implement the provisions by guidance or other sub-regulatory action.
No publicly available information on overall federal costs, savings, or budget estimates is included in the bill text or metadata.
No publicly available information on proponents' stated arguments or findings is included in the bill text or metadata.
No publicly available information on opponents' stated arguments or findings is included in the bill text or metadata.